Maturitas
Volume 55, Issue 1 , Pages 14-18 , 20 August 2006

The effect of oestrogen on cytokine and antioxidant levels in male to female transsexual patients

  • Rhoda Wilson

      Affiliations

    • Division of Cardiovascular Sciences, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 141 211 5418.
    • ,
  • Carol Jenkins

      Affiliations

    • Division of Cardiovascular Sciences, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    • ,
  • Helen Miller

      Affiliations

    • Division of Cardiovascular Sciences, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
    • ,
  • Susan Carr

      Affiliations

    • Sandyford Initiative, Sandyford Place, Sauchiehall Street, Glasgow, UK

Received 8 February 2005 ,Revised 20 December 2005 ,Accepted 3 January 2006.

References 

  1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekers CH. Menopause and the risk of coronary heart disease in women. New Eng J Med. 1987;316:1105–1110
  2. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med. 1984;76:4–12
  3. Hulley SB, Grady D. The WHI Estrogen alone trial—do things look any better?. J Am Med Assoc. 2004;219:1769–1771
  4. Subbiah MTR. Estrogen replacement therapy and cardio protection: mechanisms and controversies. Braz J Med Biol Res. 2002;35:271–276
  5. Walsh BW, Sciff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New Eng J Med. 1991;325:1196–1206
  6. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988;11:954–963
  7. Rosselli M, Imthurn B, Macas E, Keller PJ, Dubey RK. Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun. 1994;202:1543–1545
  8. Cicinelli E, Ignarro LJ, Schonauer LM, Matteo G, Galantino P, Balzano G. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril. 1998;67:58–61
  9. Ayers S, Abpianalp W, Liu JH, Subbiah MTR. Mechanisms involved in the protective effects of oestradiol_17β on lipid peroxidation and DNA damage. Am J Physiol. 1998;274:1002–1008
  10. Davidson S, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab. 2003;88:2470–2478
  11. Van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol. 1998;48:347–354
  12. Toorians AWFT, Thomassen MCLGD, Zweegman S, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab. 2003;88:5723–5729
  13. Miller H, Wilson R, Jenkins C, Roberts J, Walker JJ. Glutathione influences the TH1/TH2 response. Fertil Steril. 2000;74
  14. Lipid research clinics programme. Manual of laboratory operations, vol. 1. Lipid and lipoprotein analysis. Bethesda, MD: National Institute of Health DHEW Publications (NIH); 1971. p. 75.
  15. McCrohon JA, Walters WAW, Robinson JTC, et al. Arterial re-activity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol. 1997;29:1432–1436
  16. New G, Timmins KL, Duffy SJ, et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 1997;29:1437–1444
  17. Damewood MD, Bellantoni JJ, Bachorik , et al. Exogenous estrogen effects on lipids/lipoprotein cholesterol in transsexual males. J Endocrinol Invest. 1989;12:449–45418
  18. Ozden S, Dildar K, Kadir YH, Gulizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas. 2001;38:165–170
  19. Akcay T, Dincer Y, Kayali R, Colgar U, Oral E, Cakatay U. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J Toxicol Environ Health. 2000;59:1–5
  20. Valenti S, Fazzuoli L, Giusti M. Circulating nitric oxide levels increase after anti-androgen treatment in male-to-female transsexuals. J Endocrinol Invest. 2003;26:522–526
  21. Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J, Mylsliwski . A Effects of oestrogen deprivation on interleukin 6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol. 2002;172:387–395
  22. Davidson S, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Enodrinol Metab. 2003;88:2470–2478

PII: S0378-5122(06)00003-X

doi: 10.1016/j.maturitas.2006.01.001

Maturitas
Volume 55, Issue 1 , Pages 14-18 , 20 August 2006

Article Tools